Shire wins in DNJ in case over the hyperactivity drug Vyvanse
Reuters noted that DNJ granted Shire's summary judgment motion in a lawsuit against five generic drug producers [ Actavis, Amneal, Mylan, Roxane and Novartis's Sandoz unit ], holding that patent claims protecting its medicine were both infringed and valid.
link: http://in.reuters.com/article/2014/06/25/shire-vyvanse-idINFWN0OZ04720140625
0 Comments:
Post a Comment
<< Home